(100 days)
Not Found
No
The summary describes a mechanical device that uses physical pathways to manage airflow, with no mention of AI/ML terms or data processing that would suggest such technology.
Yes
The device is indicated for use in the treatment of obstructive sleep apnea (OSA), which makes it a therapeutic device.
No
The device is indicated for treatment ("treatment of obstructive sleep apnea (OSA)"), not diagnosis. Its description also focuses on a therapeutic mechanism (directing expiratory flow to increase intranasal pressure).
No
The device description explicitly states it is a physical device placed inside the nostrils, directing expiratory flow. This indicates a hardware component, not a software-only device.
Based on the provided information, the PROVENT® Sleep Apnea Therapy Device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "treatment of obstructive sleep apnea (OSA)." This is a therapeutic purpose, not a diagnostic one.
- Device Description: The device is placed in the nostrils and affects airflow to treat a condition. It does not analyze biological samples (like blood, urine, or tissue) to diagnose a disease or condition.
- Lack of IVD Characteristics: The description doesn't mention any analysis of biological samples, chemical reactions, or diagnostic measurements typically associated with IVDs.
IVDs are devices used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The PROVENT device does not fit this description.
N/A
Intended Use / Indications for Use
The PROVENT® Sleep Apnea Therapy Device is indicated for use in the treatment of obstructive sleep apnea (OSA).
Product codes (comma separated list FDA assigned to the subject device)
OHP
Device Description
The PROVENT device is placed just inside the nostrils. The device directs expiratory flow through selected pathways, which increases intranasal pressure similar to the expiratory portion of the breathing cycle during CPAP use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical and clinical testing demonstrated substantial equivalence of the modified devices to the predicate devices when used according to the intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.
(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”
0
510(k) Summary
| 510(k) Applicant: | Ventus Medical, Inc.
1301 Shoreway Road, Suite 425
Belmont, CA 94002
(650) 632-4189 (phone)
(650) 632-4198 (fax) |
|------------------------|------------------------------------------------------------------------------------------------------------------------------|
| | DEC 9 2010 |
| Contact: | Mike Nevares
Director, Quality & Regulatory |
| Date Summary Prepared: | August 20, 2010 |
| Name of Device: | PROVENT® Sleep Apnea Therapy:
• PROVENT 80 (PROVENT HR)
• PROVENT 50 (PROVENT SR) |
| Common Name: | Intraoral device |
| Classification Name: | Intraoral devices for snoring and intraoral devices for
snoring and obstructive sleep apnea (21 CFR 872.5570) |
| Product Code: | OHP |
| Predicate Devices: | Provent™ Professional Sleep Apnea Therapy, K071560
Provent™ Professional Sleep Apnea Therapy, K090398 |
Device Description
The PROVENT device is placed just inside the nostrils. The device directs expiratory flow through selected pathways, which increases intranasal pressure similar to the expiratory portion of the breathing cycle during CPAP use.
Indications for Use
For the treatment of obstructive sleep apnea (OSA).
Performance Data
Non-clinical and clinical testing demonstrated substantial equivalence of the modified devices to the predicate devices when used according to the intended use.
1
Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features an abstract design of an eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle emblem.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ventus Medical Incorporated c/o Mr. Michael P. Nevares Director, Quality and Regulatory 1301 Shoreway Road, Suite 425 Belmont, CA 94002
DEC 2 2010
Re: K102404 Trade/Device Name: PROVENT® Sleep Apnea Therapy
Regulation Number: 21 CFR 872.5570 Regulation Name: Intraoral Devices for Snoring, and Intraoral Devices for Snoring and Obstructive Sleep Apnea
Obstructive Sleep Apnea
Class II
Regulatory Class: Class II Product Code: OHP Dated: August 27, 2010 Received: September 30, 2010
Dear Mr. Nevares:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
2
Page 2 - Mr. Michael P. Nevares
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Quk. Then mf
Malvina B. Eydelman, M Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Ventus Medical, Inc.
Special 510(k)
Indications for Use
510(k) Number (if known):
Device Name: PROVENT® Sleep Apnea Therapy:
- . PROVENT 80
- PROVENT 50 .
Indications for Use:
The PROVENT® Sleep Apnea Therapy Device is indicated for use in the treatment of obstructive sleep apnea (OSA).
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Anakut
(Division S Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
Page 1 of
Confidential
510(k) Number K102404
Page 31